When I first valued prima for long term investment I only had dedredon as a comparator for thisr ather new technology.
So looking fwd to what the future may hold I was looking at 5bil as a potential target making prr $5 based on successful FDA approval. With absolute hope of 8-10bil long term
Now what can we expect? With dendredon at 1-2bil. We are only looking at $1-2 after FDA approval.
Can anyone help me justify anything better than what I'm valuing with risk still there of a failure? Without telling me it's still not a bad target and that dndn will sort themselves out in the current environment.
Tough times for all coming I believe
When I first valued prima for long term investment I only had...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
0.025(8.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 34.8¢ | 31.3¢ | $1.379M | 4.179M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 170360 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 115131 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |